RED ALERT
THE WEEK India|October 06, 2024
In India's quest to control thalassaemia, the most crucial aspect is the availability of safe blood v
Mohit Sharma
RED ALERT

Nishtha Madan was diagnosed with thalassaemia when she was seven months old. "I wanted to overcome the limitations attached with the disease," says Madan, now 35, and a special educator and development psychologist with the department of education, Delhi. "The credit of keeping me healthy goes to my parents. When I became an adult, I started trying to make myself more aware of the disease."

Thalassaemia is a genetic blood disorder characterised by the reduced production of haemoglobin, the protein in red blood cells that carries oxygen throughout the body. It results in anaemia and can lead to severe health complications. Official figures say that there are nearly one lakh thalassaemia patients in India, with 10,000-15,000 new cases reported annually.

The country has one of the highest prevalence rates in the world, with regions such as Punjab, Gujarat and parts of the northeast showing particularly high carrier rates. "The situation is pretty bad in peripheral areas where awareness is low," says Dr Piyasi Basu Thal, a thalassaemia-major patient herself. Thalassaemia-major, the most severe form of the disorder, requires regular (two-three weeks) blood transfusions to manage symptoms and prevent complications. "It is like we are sitting on a volcano all the time," says Namitha Kumar, 46, who was diagnosed when she was four.

While the psychological burden of thalassaemia is telling, the economic cost is also significant. "Although thalassaemia is listed as a disability, there is no benefit for the patients. The government needs to bring reservation in education and employment for thalassaemia patients," demands Madan.

Kumar, who has a PhD from the National Institute of Advanced Studies in Bengaluru, agrees. “Despite paying taxes, I get no financial support from the government,” says the academic who works with Opford, a platform for rare diseases. “I can afford health insurance but there are several others who cannot.”

This story is from the October 06, 2024 edition of THE WEEK India.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the October 06, 2024 edition of THE WEEK India.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM THE WEEK INDIAView All
Mothers, sisters and the 'c' words
THE WEEK India

Mothers, sisters and the 'c' words

A video of Paralympic gold medallist Navdeep Singh abusing after throwing his javelin in Paris went viral.

time-read
2 mins  |
October 06, 2024
WHEN STUFF OWNS US
THE WEEK India

WHEN STUFF OWNS US

There is a hoarder in all of us in some measure, but it can become a mental health condition when it seriously impairs one's life and the safety of others

time-read
10+ mins  |
October 06, 2024
I, me and myself
THE WEEK India

I, me and myself

Why narcissism is the second-hand smoke of mental disorders

time-read
3 mins  |
October 06, 2024
Don't make light of this
THE WEEK India

Don't make light of this

While the world focuses on plastic waste, chemical pollutants in oceans and smog-filled air, one sneaky culprit often goes unnoticed: light pollution.

time-read
2 mins  |
October 06, 2024
CATCHING UP ON SLEEP ON WEEKENDS COULD LOWER HEART DISEASE RISK
THE WEEK India

CATCHING UP ON SLEEP ON WEEKENDS COULD LOWER HEART DISEASE RISK

PEOPLE WHO SLEEP in on weekends can lower their risk of heart disease, finds a Chinese study presented at the European Society of Cardiology's annual meeting.

time-read
1 min  |
October 06, 2024
MIGRAINE DRUG MAY STOP SYMPTOMS BEFORE HEADACHE STARTS
THE WEEK India

MIGRAINE DRUG MAY STOP SYMPTOMS BEFORE HEADACHE STARTS

TAKING THE MEDICATION ubrogepant at the first signs of a migraine attack can prevent debilitating headaches before they start and help people go about their daily lives with little or no symptoms, finds a new US study published in the journal Neurology.

time-read
1 min  |
October 06, 2024
HIGH BLOOD PRESSURE, VISION PROBLEMS LINKED TO DEMENTIA RISK?
THE WEEK India

HIGH BLOOD PRESSURE, VISION PROBLEMS LINKED TO DEMENTIA RISK?

ACCORDING TO TWO STUDIES, untreated high blood pressure and vision impairment can increase the risk of dementia.

time-read
2 mins  |
October 06, 2024
WEEKLY INSULIN AS EFFECTIVE AS DAILY DOSES
THE WEEK India

WEEKLY INSULIN AS EFFECTIVE AS DAILY DOSES

A NEW CLASS OF WEEKLY insulin shots are as safe and effective as daily insulin injections for patients with type 1 and type 2 diabetes, according to the results of two phase 3 clinical trials presented at the European Association for the Study of Diabetes annual meeting.

time-read
1 min  |
October 06, 2024
3-IN-1 BLOOD PRESSURE PILL MORE EFFECTIVE THAN STANDARD CARE
THE WEEK India

3-IN-1 BLOOD PRESSURE PILL MORE EFFECTIVE THAN STANDARD CARE

A NEW 3-IN-1 blood pressure pill outperformed standard medication at lowering blood pressure in patients with uncontrolled hypertension.

time-read
1 min  |
October 06, 2024
DO MOBILE PHONES CAUSE CANCER?
THE WEEK India

DO MOBILE PHONES CAUSE CANCER?

A WORLD HEALTH Organization-commissioned review of previously published studies worldwide has found no link between cellphone use and brain cancer.

time-read
1 min  |
October 06, 2024